Greg Rossi

757 total citations
19 papers, 581 citations indexed

About

Greg Rossi is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Greg Rossi has authored 19 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Genetics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Greg Rossi's work include Erythropoietin and Anemia Treatment (16 papers), Iron Metabolism and Disorders (8 papers) and Hemoglobinopathies and Related Disorders (7 papers). Greg Rossi is often cited by papers focused on Erythropoietin and Anemia Treatment (16 papers), Iron Metabolism and Disorders (8 papers) and Hemoglobinopathies and Related Disorders (7 papers). Greg Rossi collaborates with scholars based in United States, Spain and Australia. Greg Rossi's co-authors include Dianne Tomita, Veena Charu, Lee S. Schwartzberg, Angelo Pompucci, R. Roselli, Massimo Scerrati, Maurizio Iacoangeli, John A. Glaspy, Lorrin Yee and Joel Wallace and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Greg Rossi

18 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Rossi United States 12 439 179 164 107 82 19 581
Michael Shephard United States 7 41 0.1× 44 0.2× 10 0.1× 93 0.9× 150 1.8× 10 471
Wilfried Roeloffzen Netherlands 8 65 0.1× 30 0.2× 33 0.2× 9 0.1× 30 0.4× 23 259
McDonald Tp United States 11 302 0.7× 77 0.4× 19 0.1× 12 0.1× 24 0.3× 22 379
M‐C. Poon Canada 7 298 0.7× 58 0.3× 28 0.2× 6 0.1× 10 0.1× 8 379
S Glazer Denmark 6 355 0.8× 87 0.5× 16 0.1× 2 0.0× 24 0.3× 10 561
G. Krajnik Austria 9 71 0.2× 21 0.1× 4 0.0× 41 0.4× 250 3.0× 19 374
Wasserman Lr 6 220 0.5× 258 1.4× 14 0.1× 16 0.1× 7 0.1× 15 338
Emma L. Court United Kingdom 10 42 0.1× 25 0.1× 16 0.1× 8 0.1× 43 0.5× 15 287
Moetaza M. Soliman Egypt 9 126 0.3× 82 0.5× 2 0.0× 11 0.1× 31 0.4× 24 449
Jonathan Tucci United States 10 96 0.2× 39 0.2× 1 0.0× 110 1.0× 98 1.2× 21 413

Countries citing papers authored by Greg Rossi

Since Specialization
Citations

This map shows the geographic impact of Greg Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Rossi more than expected).

Fields of papers citing papers by Greg Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Rossi. The network helps show where Greg Rossi may publish in the future.

Co-authorship network of co-authors of Greg Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Rossi. A scholar is included among the top collaborators of Greg Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Rossi. Greg Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ruau, David, B Griffiths, Greg Rossi, et al.. (2025). The AI revolution: how multimodal intelligence will reshape the oncology ecosystem. 1(1). 1 indexed citations
2.
Gabrilove, Janice, Edith A. Perez, Dianne Tomita, Greg Rossi, & Charles S. Cleeland. (2007). Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy‐induced anemia. Cancer. 110(7). 1629–1640. 30 indexed citations
3.
Kotasek, Dusan, Jean-Luc Canon, María‐Victoria Mateos, et al.. (2007). A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia. Current Medical Research and Opinion. 23(6). 1387–1401. 6 indexed citations
4.
5.
Charu, Veena, Bruce Saidman, Glen R. Justice, et al.. (2007). A Randomized, Open-Label, Multicenter Trial of Immediate Versus Delayed Intervention with Darbepoetin Alfa for Chemotherapy-Induced Anemia. The Oncologist. 12(10). 1253–1263. 14 indexed citations
6.
Canon, Jean-Luc, Johan Vansteenkiste, G. Bodoky, et al.. (2006). Randomized, Double-Blind, Active-Controlled Trial of Every-3-Week Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia. JNCI Journal of the National Cancer Institute. 98(4). 273–284. 83 indexed citations
7.
Blumer, Jeffrey L., Stacey L. Berg, Peter C. Adamson, et al.. (2006). Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy‐induced anemia. Pediatric Blood & Cancer. 49(5). 687–693. 4 indexed citations
8.
Heatherington, Anne C., Christian Dittrich, John T. Sullivan, Greg Rossi, & Johannes Schueller. (2006). Pharmacokinetics of Darbepoetin Alfa after Intravenous or Subcutaneous Administration in Patients with Non-myeloid Malignancies Undergoing Chemotherapy. Clinical Pharmacokinetics. 45(2). 199–211. 11 indexed citations
9.
Patton, Jeffrey, et al.. (2006). A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome.. PubMed. 3(6). 419–26. 13 indexed citations
10.
Glaspy, John A., Saroj Vadhan‐Raj, Ravi Patel, et al.. (2006). Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: The 20030125 Study Group Trial. Journal of Clinical Oncology. 24(15). 2290–2297. 59 indexed citations
11.
12.
Senecal, Frank M., Lorrin Yee, Nashat Gabrail, et al.. (2005). Treatment of Chemotherapy-Induced Anemia in Breast Cancer: Results of a Randomized Controlled Trial of Darbepoetin Alfa 200 μg Every 2 Weeks Versus Epoetin Alfa 40,000 U Weekly. Clinical Breast Cancer. 6(5). 446–454. 20 indexed citations
13.
14.
15.
Schwartzberg, Lee S., Lorrin Yee, Frank M. Senecal, et al.. (2004). A Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia in Patients With Breast, Lung, or Gynecologic Cancer. The Oncologist. 9(6). 696–707. 80 indexed citations
16.
Boccia, Ralph V., Delong Liu, Peter T. Silberstein, et al.. (2004). An Evaluation of the Effectiveness of Darbepoetin alfa 300 mcg Every 3 Weeks (Q3W) on Clinical Outcomesin Cancer Patients with Chemotherapy-Induced Anemia.. Blood. 104(11). 5310–5310. 2 indexed citations
17.
Glaspy, John A. & Greg Rossi. (2004). Author reply. Cancer. 100(7). 1546–1546.
18.
19.
Scerrati, Massimo, R. Roselli, Maurizio Iacoangeli, Angelo Pompucci, & Greg Rossi. (1996). Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.. Journal of Neurology Neurosurgery & Psychiatry. 61(3). 291–296. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Shephard Breakdown of academic impact, for papers by Wilfried Roeloffzen Breakdown of academic impact, for papers by McDonald Tp Breakdown of academic impact, for papers by M‐C. Poon Breakdown of academic impact, for papers by S Glazer Breakdown of academic impact, for papers by G. Krajnik Breakdown of academic impact, for papers by Wasserman Lr Breakdown of academic impact, for papers by Emma L. Court Breakdown of academic impact, for papers by Moetaza M. Soliman Breakdown of academic impact, for papers by Jonathan Tucci
Rankless by CCL
2026